Subgroup Could Give Xpovio Focused Commercial Opportunity In Endometrial Cancer

 
• By Alaric DeArment
  
Digital illustration of Cancer cell in colour background
Karyopharm announced topline results from its Phase III SIENDO trial in endometrial cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas